Thyroid Cancer

Thyroid cancer is a disease in which cancer cells are found in tissues of the thyroid, a gland at the base of the throat.  It occurs most often in people between the ages of 25 and 65 and is more common in women than in men.  More than 25,000 people are diagnosed with thyroid cancer in the United States each year.

The Thyroid Cancer Unit of the OSU CCC-James represents a unique collaboration among clinicians, researchers and basic scientists from different and complimentary backgrounds.  Members of the group, all with an interest in thyroid cancer, include:

  • Endocrinologists
  • Oncologists
  • Geneticists
  • Pathologists
  • Surgeons
  • Veterinarians
  • Pharmacologists
  • Cell and molecular biologists

The OSU CCC-James occupies a unique place in the landscape of thyroid cancer, with patient-based studies of this disease dating back over 40 years.  In this spirit, we aim not only to continue the historical presence of OSU as a central repository of learning about thyroid cancer, but to expand its role in terms of both understanding this disease and developing new treatments for the increasing numbers of patients with this diagnosis.

The OSU CCC-James Thyroid Cancer Unit is the largest group of its kind in the United States.  It has as its goals:

  • The elucidation of genetic factors that cause the initiation of thyroid cancer cells
  • The understanding of cellular changes that affect the growth and spread of thyroid cancer|
  • An analysis of how different treatment agents affect thyroid cancer cells
  • The development of newer, targeted agents that will improve treatment strategies for thyroid cancer

The advantage of such a large group is that it allows the free exchange of ideas, which flow from the patient to the biology laboratory, from the laboratory to drug development, from drug development to animal studies, and eventually back to the patient.  Ideas can also flow in the other direction, leading to an organization that is much stronger than the sum of its parts.

In the same way as we envision our own integrated working environment, we have tried to produce a Web site that will allow any outside visitor with an interest in thyroid cancer to find the latest information about us, our research, or the current status of treatments for thyroid cancer.

Although it is commonly believed that thyroid cancer is a benign disease, our experience with patients over the years tells us that this is not always the case.  We dedicate ourselves and our research to the improvement of this condition for all patients.

For questions about thyroid cancer, please call The James Line – a free cancer information resource and physician referral service – at (614) 293-5066 or 1-800-293-5066 (outside Franklin County) or e-mail now. The James Line oncology nurses can be reached Monday-Friday 8:00 a.m.-5:00 p.m. (except weekends and holidays). View The James' thyroid cancer fact sheet.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu